Finally, it should be noted that TERT promoter mutations are frequently present in oligodendroglioma similarly to IDH-wildtype glioblastoma; this finding further highlights the importance of interpreting each molecular marker within the whole histopathological and clinical context. This evidence concerns the gene IDH1 and glioblastoma.